These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 27059345)

  • 1. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala.
    Gastañaduy PA; Contreras-Roldán I; Bernart C; López B; Benoit SR; Xuya M; Muñoz F; Desai R; Quaye O; Tam KI; Evans-Bowen DK; Parashar UD; Patel M; McCracken JP
    Clin Infect Dis; 2016 May; 62 Suppl 2():S121-6. PubMed ID: 27059345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study.
    Gastañaduy PA; Steenhoff AP; Mokomane M; Esona MD; Bowen MD; Jibril H; Pernica JM; Mazhani L; Smieja M; Tate JE; Parashar UD; Goldfarb DM
    Clin Infect Dis; 2016 May; 62 Suppl 2():S161-7. PubMed ID: 27059351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
    Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua.
    Patel M; Pedreira C; De Oliveira LH; Tate J; Orozco M; Mercado J; Gonzalez A; Malespin O; Amador JJ; Umaña J; Balmaseda A; Perez MC; Gentsch J; Kerin T; Hull J; Mijatovic S; Andrus J; Parashar U
    JAMA; 2009 Jun; 301(21):2243-51. PubMed ID: 19491186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
    Patel M; Pedreira C; De Oliveira LH; Umaña J; Tate J; Lopman B; Sanchez E; Reyes M; Mercado J; Gonzalez A; Perez MC; Balmaceda A; Andrus J; Parashar U
    Pediatrics; 2012 Aug; 130(2):e365-72. PubMed ID: 22753550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.
    Doll MK; Buckeridge DL; Morrison KT; Gagneur A; Tapiero B; Charest H; Quach C
    Vaccine; 2015 Dec; 33(51):7307-7314. PubMed ID: 26546262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia.
    Beres LK; Tate JE; Njobvu L; Chibwe B; Rudd C; Guffey MB; Stringer JS; Parashar UD; Chilengi R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S175-82. PubMed ID: 27059353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Rotavirus Strains Affect Vaccine Effectiveness? A Systematic Review and Meta-analysis.
    Cates JE; Amin AB; Tate JE; Lopman B; Parashar U
    Pediatr Infect Dis J; 2021 Dec; 40(12):1135-1143. PubMed ID: 34870393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of monovalent and pentavalent rotavirus vaccine.
    Cortese MM; Immergluck LC; Held M; Jain S; Chan T; Grizas AP; Khizer S; Barrett C; Quaye O; Mijatovic-Rustempasic S; Gautam R; Bowen MD; Moore J; Tate JE; Parashar UD; Vázquez M
    Pediatrics; 2013 Jul; 132(1):e25-33. PubMed ID: 23776114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.
    Payne DC; Boom JA; Staat MA; Edwards KM; Szilagyi PG; Klein EJ; Selvarangan R; Azimi PH; Harrison C; Moffatt M; Johnston SH; Sahni LC; Baker CJ; Rench MA; Donauer S; McNeal M; Chappell J; Weinberg GA; Tasslimi A; Tate JE; Wikswo M; Curns AT; Sulemana I; Mijatovic-Rustempasic S; Esona MD; Bowen MD; Gentsch JR; Parashar UD
    Clin Infect Dis; 2013 Jul; 57(1):13-20. PubMed ID: 23487388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
    Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
    Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda.
    Tate JE; Ngabo F; Donnen P; Gatera M; Uwimana J; Rugambwa C; Mwenda JM; Parashar UD
    Clin Infect Dis; 2016 May; 62 Suppl 2():S208-12. PubMed ID: 27059358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana.
    Armah G; Pringle K; Enweronu-Laryea CC; Ansong D; Mwenda JM; Diamenu SK; Narh C; Lartey B; Binka F; Grytdal S; Patel M; Parashar U; Lopman B
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S200-7. PubMed ID: 27059357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children.
    Araki K; Hara M; Tsugawa T; Shimanoe C; Nishida Y; Matsuo M; Tanaka K
    Vaccine; 2018 Aug; 36(34):5187-5193. PubMed ID: 30037664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.
    Mast TC; Khawaja S; Espinoza F; Paniagua M; Del Carmen LP; Cardellino A; Sánchez E
    Pediatr Infect Dis J; 2011 Nov; 30(11):e209-15. PubMed ID: 21768920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants.
    Chang WC; Yen C; Wu FT; Huang YC; Lin JS; Huang FC; Yu HT; Chi CL; Lin HY; Tate JE; Parashar UD; Wu HS; Hsiung CA
    Pediatr Infect Dis J; 2014 Mar; 33(3):e81-6. PubMed ID: 24569388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses.
    Bar-Zeev N; Jere KC; Bennett A; Pollock L; Tate JE; Nakagomi O; Iturriza-Gomara M; Costello A; Mwansambo C; Parashar UD; Heyderman RS; French N; Cunliffe NA;
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S213-9. PubMed ID: 27059359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Pentavalent Rotavirus Vaccine Against a Diverse Range of Circulating Strains in Nicaragua.
    Patel M; Pedreira C; De Oliveira LH; Tate J; Leshem E; Mercado J; Umaña J; Balmaceda A; Reyes M; Kerin T; McDonald S; Gentsch J; Bowen MD; Parashar U
    Clin Infect Dis; 2016 May; 62 Suppl 2():S127-32. PubMed ID: 27059346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
    Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
    Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Soares-Weiser K; Maclehose H; Bergman H; Ben-Aharon I; Nagpal S; Goldberg E; Pitan F; Cunliffe N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008521. PubMed ID: 22336845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.